Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

Share Price is delayed by 15 minutes
Get Live Data
954.00    4.50 (0.47%)
Bid:
955.00
Ask:
957.00
Spread: 2.00 (0.209%)
Market Cap: £861.34m
GAMA Live PriceLast checked at - London Stock Exchange

Intraday Gamma Communications Share Chart

H1 Trading Update

2 Aug 2022 07:00

RNS Number : 5294U
Gamma Communications PLC
02 August 2022
Ā 

Gamma Communications plcH1 trading update

Strong first half performance, continued cash generation and positive business momentum

Gamma Communications plc ("Gamma" or the "Group"), a leading provider of Unified Communications as a Service ("UCaaS") to the business markets in theĀ UK,Ā Germany,Ā Spain, andĀ the Netherlands, is pleased to announce a trading update for the six months ended 30 June 2022. This update confirms the statements made at the time of the AGM on 19 May 2022.

Group overview

We are pleased to report that the Group performed well through the first six months of the year with strong year on year adjusted EBITDA growth.

In both the UK and Europe our resilient recurring revenue model, combined with selected price increases and strict cost discipline, has helped mitigate inflationary pressures, ensuring that the Group has good momentum going into the second half of the year. The Group continues to proactively manage its supply chain; given the well-publicised delays in the availability of various telco/networking hardware devices we deliberately built the UK Indirect Business inventory to over twice the levels we held pre-COVID.

United Kingdom

We have seen healthy momentum in the Indirect Business which remains on track to meet our targeted 8% growth in Gross Profit for FY 2022. There has been good sales traction on key new products such as Horizon Contact.

The Direct Business has seen a number of significant MS Teams user contract wins, including the Home Office and DWP in the public sector. A strong contracted pipeline, significantly ahead when compared to this time last year, across the Direct channel gives comfort on the sizeable growth we expect for the full year. Revenue growth will approach 10% (2022 against 2021).Ā 

Overheads across the UK were within expectations during the first half and inflationary increases will continue to be challenged and tightly managed. Ā 

Europe: Germany, Netherlands and Spain

Growth in UCaaS supported a good first half German business financial performance which counterbalanced some headwinds in our smaller Spanish business. Microsoft Teams Operator Connect was launched in the Netherlands and is planned to roll out in both Germany and Spain. We will also launch our contact centre product in Spain in the second half of the year.

Product development

The Group has continued to make progress on the expansion of the capabilities it offers to its customers, across all channels and countries, leveraging its growing in-house software development capability and the range of strategic partnerships it has developed.

Cash

Gamma's balance sheet remains strong, with significant cash generation from its trading activities. Closing net cash at the half year was approximately £72.6m compared to £49.5m at the end of the previous year. This is after paying £1.7m of contingent consideration on acquisitions and making early supplier payments to receive attractive prompt payer discounts. 

Ā 

Ā 

Ā 

Outlook

The Board remains positive about the prospects for Gamma.Ā In line with the statement made at the time of the AGM, management expects adjusted EBITDA and adjusted EPS for the year ending 31 December 2022 to be in the upper half of the range of market forecasts.*

The Board will announce results for the half year ended 30 June 2022 on Tuesday 6 September 2022.

Andrew Belshaw, Interim Chief Executive, commented on the results:

"I'm very pleased to report on a strong first half performance. Gamma is leveraging the full breadth of its market-leading product set both through the channel and direct across all of our markets.

Although not immune from the macro-economic challenges ahead, our recurring revenue model, strong cash generation and healthy balance sheet enables us to continue to invest in the undoubted market opportunity. Churn and bad debt remains at low levels and these results demonstrate the resilience of the customer base and the importance they attach to Gamma's products and services.

We look forward to continuing this momentum into the second half."

Ā 

* Note: Company compiled range is based on known sell side analyst estimates. The ranges are Adjusted EBITDA £102.3m - £106.8m and Adjusted EPS 67.1 pence - 74.6 pence.

Ā 

Gamma Communications plc

Andrew Belshaw, Chief Executive Officer

Bill Castell, Chief Financial Officer

Tel: +44 (0) 333 006 5972

Tulchan Communications LLP

James Macey White / Matt Low

Tel: +44 (0) 207 353 4200

Ā 

Investec Bank plc (NOMAD & Broker)

Tel: +44 (0) 207 597 5970

Patrick Robb / Virginia Bull

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
TSTKZGGRRMKGZZM
Date   Source Headline
28th Mar 20252:56 pmRNSHolding(s) in Company
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20252:02 pmRNSHolding(s) in Company
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:01 amRNSShare buyback Programme
25th Mar 20257:00 amRNSFinal Results
17th Mar 20254:26 pmRNSHolding(s) in Company
13th Mar 202511:35 amRNSDirector/PDMR Shareholding
13th Mar 20257:05 amRNSHolding(s) in Company
20th Feb 20257:00 amRNSGamma completes acquisition of STARFACE
13th Feb 202510:02 amRNSDirector/PDMR Shareholding
6th Feb 20258:46 amRNSHolding(s) in Company
3rd Feb 20251:00 pmRNSTotal Voting Rights
21st Jan 202512:13 pmRNSHolding(s) in Company
20th Jan 20251:54 pmRNSDirector/PDMR Shareholding
14th Jan 20255:06 pmRNSDirector/PDMR Shareholding
14th Jan 20257:01 amRNSTrading Update
14th Jan 20257:00 amRNSGamma agrees to acquire STARFACE
2nd Jan 20254:47 pmRNSTotal Voting Rights
13th Dec 20242:05 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:48 pmRNSHolding(s) in Company
3rd Dec 20243:42 pmRNSHolding(s) in Company
2nd Dec 202412:37 pmRNSTotal Voting Rights
2nd Dec 20247:00 amRNSProposed Move to the Main Market
14th Nov 20248:05 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSBlock listing Interim Review
4th Nov 20247:00 amRNSTotal Voting Rights - Replacement
1st Nov 20245:45 pmRNSHolding(s) in Company
1st Nov 20242:43 pmRNSTotal Voting Rights
15th Oct 20243:32 pmRNSDirector/PDMR Shareholding
4th Oct 20242:59 pmRNSHolding(s) in Company
2nd Oct 20243:55 pmRNSDirector/PDMR Shareholding
1st Oct 20244:08 pmRNSTotal Voting Rights
27th Sep 20244:27 pmRNSHolding(s) in Company
16th Sep 202410:01 amRNSDirector/PDMR Shareholding
13th Sep 20241:55 pmRNSHolding(s) in Company
11th Sep 20246:21 pmRNSHolding(s) in Company
10th Sep 20247:10 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSHalf-year Report
9th Sep 20247:22 amRNSHolding(s) in Company
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 202412:56 pmRNSTotal Voting Rights
22nd Aug 20243:04 pmRNSHolding(s) in Company
21st Aug 202411:10 amRNSHolding(s) in Company
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSChange of Adviser
14th Aug 20247:05 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.